Haematologica 2007;92:supplement no. 4 (XXXIV AIEOP Congress)

Haematologica 2006;91:supplement no. 1 (Abstract Book 11^th Congress of the European Hematology Association)

Hematology Education 2006;1 (Education Program of the 11^th Congress of the European Hematology Association)

Haematologica 2006;91: supplement no. 4 (XXXIII Congresso Nazionale Associazione Italiana Ematologia Oncologia Pediatrica)

Haematologica 2006;91: supplement no. 3 (IX Congress of the Italian Society of Experimental Hematology - SIES)

Haematologica 2006;91: supplement no. 2 (XIX Congress of the Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET)

Haematologica 2005;90:supplement no. 1 (10^th International Myeloma Workshop)

Haematologica 2005;90:supplement no. 2 (Abstract Book 10^th Congress of the European Hematology Association)

Haematologica 2005;90:supplement no. 3 (40^th Congress of the Italian Society of Hematology)

Haematologica 2004;89:supplement no. 5 (Abstract Book 9^th Congress of the European Hematology Association)

Haematologica 2004;89:supplement no. 5 (Educational Book 9^th Congress of the European Hematology Association)

Haematologica 2004;89:5 supplement no. 1 (Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: Progress in treatment)

Haematologica 2003;88:4 supplement no. 1 (9^th International Workshop on Multiple Myeloma)

Haematologica 2004;89: supplement no. 12 (Mieloma multiplo e colonna vertebrale)

Haematologica 2004;89: supplement no. 11 (MGUS, Waldenstrom’s macroglobulinemia and multiple myeloma: Diagnostic and Therapeutic Update)

Haematologica 2004;89: supplement no. 10 (XXXI Congresso Nazionale Associazione Italiana Ematologia Oncologia Pediatrica)

Haematologica 2004;89: supplement no. 9 (Ten Years After the REAL Classification: Open Issues)

Haematologica 2004;89: supplement no. 8 (XVIII Congress of the Italian Society for Hemostasis and Thrombosis)

Haematologica 2004;89: supplement no. 7 (ADP 2004 P2 Receptors and Other, New Targets for Antithrombotic Drugs)

Haematologica 2004;89: supplement no. 6 (VIII Congress of the Italian Society of Experimental Hematology)

Haematologica 2004;89: supplement no. 5 (New Insights into the Management of Bleeding Disorders)

Haematologica 2004;89: supplement no. 4 (Breakthrough in supportive cancer care: introducing Pegfilgrastim)

Haematologica 2004;89: supplement no. 3 (Nuove prospettive nella terapia delle infezioni micotiche invasive nel paziente oncoematologico)

Haematologica 2004;89: supplement no. 2 (Break through in supportive cancer care introducing pegfilgrastim)

Haematologica 2004;89: supplement no. 1 (The Evolution of Recombinant Factors in Hemophilia: Making Theraputic Choices)

Haematologica 2003;88: supplement no. 18 (Linee Guida per la Diagnosi, la Profilassie la Terapia del Tromboembolismo Venoso)

Haematologica 2003;88: supplement no. 17 (Chronic Lymphocytic Leukemia 2003)

Haematologica 2003;88: supplement no. 16 (Nuove evidenze per la terapia empirica del paziente ematologico immunodepresso con sospetta micosi invasiva)

Haematologica 2003;88: supplement no. 15 (XXXIX Congress of the Italian Society of Hematology)

Haematologica 2003;88: supplement no. 14 (Multiple Myeloma: Update 2003)

Haematologica 2003;88:supplement no. 13 (Does Caring Fatigue Improve Survival?)

Haematologica 2003;88:supplement no. 12 (IV International Workshop on Immune Tolerance in Hemophilia and the treatment of Hemophiliacs with an Inhibitor)

Haematologica 2003;88:supplement no. 11 (La terapia della trombocitemia essenziale)

Haematologica 2003;88:supplement no. 10 (New Insights in Hematology)

Haematologica 2003;88:supplement no. 9 (Factor VII/von Willebrand Factor Complex in Hemophilia a Treatment)

Haematologica 2003;88:supplement no. 8 (La terapia del mioloma multiplo: linee guida di SIE SIES, GITMO)

Haematologica 2003;88:supplement no. 7 (La Trombosi Venosa Profonda: Presente e Futuro)

Haematologica 2003;88:supplement no. 6 (Emergencies in Hematology)

Haematologica 2003;88:supplement no. 5 (Cutaneous Lymphomas: Are They Separate Entities? Which is the Best Treatment?)

Haematologica 2003;88:supplement no. 4 (Platelets 2003)

Haematologica 2003;88:supplement no. 3 (Self-Testing and Self-Monitoring of Oral Anticoagulant Therapy: Consensus of the Italian Federation of Anticoagulation Clinics)

Haematologica 2003;88:supplement no. 2 (A guide to oral anticoagulant treatment. Recommendations of the Italian Federation of Anticoagulation Clinics)

Haematologica 2002;87:supplement 1 to no. 10 (The Platelet ADP Receptors)

Haematologica 2002;87:supplement 2 to no. 10 (Chronic lymphocytic leukemia: is it a curable disease?)

Haematologica 2002;87:supplement 3 to no. 10 (Fattori di crescita in oncoematologia: uso appropriato e prospettive future)

Haematologica 2002;87:supplement 1 to no. 9 (VII Congress of the Italian Society of Experimental Hematology)

Haematologica 2002;87: supplement to no. 8 (Present and Future of Hematopoietic Stem Cell Transplantation)

Haematologica 2002;87: supplement to no. 7 (La terapia nei linfomi non Hodgkin aggressivi dell'anziano)

Haematologica 2002;87: supplement 1 to no. 6 (Allogeneic Hematopoietic Cell Transplantation for Solid Tumors)

Haematologica 2002;87: supplement 2 to no. 5 (Old and New Heparins)

Haematologica 2002;87: supplement to no. 5 (XVII Congress of the Italian Society for Hemostasis and Thrombosis)

Haematologica 2002;87: supplement to no. 4 (Linee guida SISET per la profilassi del tromboembolismo venoso in chirurgia ortopedica maggiore)

Haematologica 2002;87: supplement to no. 3 (La terapia delle sindromi mielodisplastiche. Linee guida basate su evidenza e consenso)

Haematologica 2002;87: supplement to no. 1 (GEIL 2002 Immunology and Leukemias)

Haematologica 2001;86:supplement to no. 9 (Linee guida SISET sulla terapia antitrombotica nella fibrillazione atriale)

Haematologica 2001;86:supplement 2 to no. 10 (Satellite Symposium 38^th Congress of the Italian Society of Hematology Florence, von Willebrand’s disease)

Haematologica 2001;86:supplement to no. 10 (38^th Congress of the Italian Society of Hematology)

Haematologica 2001;86:supplement no. 11 (Myelodysplastic syndromes: recent advances)

Haematologica 2001;86:supplement 2 to no. 11 (Platelets 2001)

Haematologica 2001;86:supplement 1 to no. 11 (New Drugs in Hematologic Malignancies)

Haematologica 2000;85:supplement to no. 12 (Raccolta Dompé)

Haematologica 2000;85:supplement to no. 11 (Hematopoietic stem cell transplantation in pediatric oncologic-hematologic and autoimmune diseases)

Haematologica 2000;85:supplement to no. 10 (Immune Tolerance in Hemophilia and the Treatment of Hemophiliacs with an Inhibitor)

Haematologica 2000;85:supplement to no. 9 (VI Congress of the Italian Society of Experimental Hematology)

Haematologica 2000;85:supplement to no. 7 (New Insights in Hematology)

Haematologica 2000;85:supplement to no. 5 (XVI Congress of the Italian Society for Hemostasis and Thrombosis)

Haematologica 2000;85:supplement no. 5 (Educational Book dedicated to the 5^th Congress of the European Haematology Association)

Haematologica 2000;85:supplement no. 5 (Abstract Book dedicated to the 5^th Congress of the European Haematology Association)

Haematologica 2000;85:supplement no. 2 (XLII Reunion Nacional de la AEHH y XVI Congreso de la SETH)

Haematologica 2000;85:supplement ADP (The Platelet ADP receptors. Biochemistry, physiology, pharmacology and clinical aspects)

Haematologica 2000;85:supplement the Jubilee Meeting on CML (Jubilee Meeting on Chronic Myeloid Leukemia)

Haematologica 1999;84: supplement to no. 10 (Indolent Lymphoma Workshop)

Haematologica 1999;84: supplement to no. 9 (37^th Congress of the Italian Society of Hematology)

Haematologica 1999;84:supplement no. 4 (Abstract Book for the Fourth Congress of the European Haematology Association)

Haematologica 1999;84:supplement no. 4 (Educational Book for the Fourth Congress of the European Haematology Association)

Haematologica 1998;83:supplement to no. 9 (36^th Congress of the Italian Society of Hematology)

Haematologica 1998;83:meeting supplement (XIII Congress of the Italian Association of Immunopharmacology)

Haematologica 1997;82:supplement to no. 5 (Symposium Idarubicin: new pharmacological insights and clinical applications)

Haematologica 1996;81:supplement to no. 2 (35^th Congress of the Italian Society of Hematology)

Haematologica 1995;80:supplement to no. 2 (Basic, Laboratory and Clinical Aspects of Venous Thromboembolism)

Haematologica 1994;79:supplement to no. 4 (3^rd Congress of the Italian Society of Experimental Hematology)

Haematologica 1994;79:supplement to no. 2 (Meccanismi di crescita delle leucemie mieloidi acute - L’ibridazione in situ nel paziente onco-ematologico)

Haematologica 1993;78:supplement no. 5 (Stem cell factor: aspetti biologici e possibili applicazioni cliniche
Oligonucleotidi antisenso)

Haematologica 1993;78:supplement no. 1 (Apoptosi: significato biologico e clinico Colture a lungo termine: aspetti e applicazioni cliniche)